Amphenol (APH) officer sells 80,000 shares after option exercise
Amphenol (APH) insider transaction: An officer identified as President, CS Division reported an option exercise and same‑day sale on 10/29/2025.
Rhea-AI Filing Summary
Amphenol (APH) insider transaction: An officer identified as President, CS Division reported an option exercise and same‑day sale on 10/29/2025. The filing shows an exercise of 80,000 stock options at an exercise price of $33.295 per share (code M), followed by an open market sale of 80,000 Class A Common shares (code S) at a $141.0366 weighted average price, with trades ranging from $141.00 to $141.1550.
Following these transactions, the filing lists 0 non‑derivative shares beneficially owned and 186,000 derivative securities (stock options) beneficially owned. The stock option series exercised was originally exercisable on 05/20/2022 and expires on 05/20/2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 80,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 80,000 | $33.295 | $2.66M |
| Sale | Class A Common Stock | 80,000 | $141.0366 | $11.28M |
Footnotes (2)
- F1. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. This transaction was executed in multiple trades ranging from $141.00 to $141.1550.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amphenol (APH) report in this Form 4?
What is the officer’s beneficial ownership after the transactions?
What were the terms of the exercised Amphenol stock options?
Who is the reporting person in relation to Amphenol (APH)?
Did the Form 4 indicate Rule 10b5-1 plan use?
AI-generated analysis. How Rhea-AI works. Not financial advice.